Fresenius Medical Care AG & Co. KGaA

Research Fresenius Medical Care AG & Co. KGaA (FMS) on Bullrun: valuation model: 51.1% undervalued, market cap USD 12.26B, P/E 11.9, dividend yield 3.8%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerFMS
• ExchangeNYSE
• CountryGermany
• SectorHealthcare
• IndustryMedical Care Facilities
• CurrencyUSD
• Valuation signal51.1% undervalued
• Market capUSD 12.26B
• P/E11.9
• Dividend yield3.8%
• Financial periodFY2016
• Net incomeUSD 1.24B
• Free cash flowUSD 1.11B

Valuation Snapshot

Bullrun's latest valuation model marks Fresenius Medical Care AG & Co. KGaA as 51.1% undervalued; latest market cap is USD 12.26B; P/E is 11.9; dividend yield is 3.8%.

About Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence;

Frequently asked questions

Is Fresenius Medical Care AG & Co. KGaA overvalued or undervalued?

Bullrun's valuation model currently marks Fresenius Medical Care AG & Co. KGaA as 51.1% undervalued.

What is Fresenius Medical Care AG & Co. KGaA's market cap?

Fresenius Medical Care AG & Co. KGaA's market capitalization is USD 12.26B.

What is Fresenius Medical Care AG & Co. KGaA's P/E ratio?

Fresenius Medical Care AG & Co. KGaA's price-to-earnings (P/E) ratio is 11.9.

Does Fresenius Medical Care AG & Co. KGaA pay a dividend?

Fresenius Medical Care AG & Co. KGaA has a dividend yield of 3.8%.

What does Fresenius Medical Care AG & Co. KGaA do?

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics;